Responses
Other content recommended for you
- Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981–2014: a retrospective observational study
- Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report
- Rethinking the appraisal and approval of drugs for type 2 diabetes
- Prescribing new drugs: qualitative study of influences on consultants and general practitioners
- Public sector financial support for late stage discovery of new drugs in the United States: cohort study
- Speeding new antibiotics to market: a fake fix?
- Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials
- Fitting the drug to the patient
- Decline in new drug launches: myth or reality? Retrospective observational study using 30 years of data from the UK
- Clinical Research and Drug Development in Latin America